4.7 Article

Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders

Elia Sechi et al.

Summary: MOGAD patients more frequently experience complete resolution of MRI T2 lesions compared to AQP4-IgG-NMOSD and MS. This finding has implications for diagnosis, disease activity monitoring, and clinical trial design, while also providing insights into the pathogenesis of CNS demyelinating diseases.

NEUROLOGY (2021)

Article Clinical Neurology

MRI differences between MOG antibody disease and AQP4 NMOSD

Sara Salama et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Clinical Neurology

Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder

Min Young Lee et al.

NEUROLOGY (2020)

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Article Clinical Neurology

Clinical presentation and prognosis in MOG-antibody disease: a UK study

Maciej Jurynczyk et al.

Article Clinical Neurology

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

Patrick Waters et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)

Article Clinical Neurology

Serologic diagnosis of NMO A multicenter comparison of aquaporin-4-IgG assays

P. J. Waters et al.

NEUROLOGY (2012)